Simple animal models for amyotrophic lateral sclerosis drug discovery. (2nd August 2016)

• Record Type: Journal Article
• Authors: Patten, Shunmoogum A.; Parker, J. Alex; Wen, Xiao-Yan; Drapeau, Pierre
• Is Part Of: Expert opinion on drug discovery. Volume 11:Number 8(2016:Aug.)
• Page Start: 797
• Page End: 804
• Publication Date: 2016-08-02
• Subjects: Amyotrophic lateral sclerosis -- C. elegans -- chemical genetics -- Drosophila -- drug discovery -- zebrafish; 615.1
• DOI: 10.1080/17460441.2016.1196183
• Languages: English
• ISSNs: 1746-0441

Abstract

ABSTRACT: Introduction : Simple animal models have enabled great progress in uncovering the disease mechanisms of amyotrophic lateral sclerosis (ALS) and are helping in the selection of therapeutic compounds through chemical genetic approaches. Areas covered : Within this article, the authors provide a concise overview of simple model organisms, C. elegans, Drosophila and zebrafish, which have been employed to study ALS and discuss their value to ALS drug discovery. In particular, the authors focus on innovative chemical screens that have established simple organisms as important models for ALS drug discovery. Expert opinion : There are several advantages of using simple animal model organisms to accelerate drug discovery for ALS. It is the authors' particular belief that the amenability of simple animal models to various genetic manipulations, the availability of a wide range of transgenic strains for labelling motoneurons and other cell types, combined with live imaging and chemical screens should allow for new detailed studies elucidating early pathological processes in ALS and subsequent drug and target discovery.